6S-5-Methyltetrahydrofolate vs Folic Acid for Folate Maintenance During Lactation
06/14/2026 15:07:17
This 16-week randomized double-blind placebo-controlled trial, published in the American Journal of Clinical Nutrition, addresses a longstanding gap in lactation folate nutrition research. Even with mandatory folic acid fortification in North America, lactating women who stop high-dose prenatal folic acid supplements commonly experience rapid blood folate declines, driven by breastfeeding demands and reduced supplemental intake. High-quality L-methylfolate bulk powder has become a preferred raw material for manufacturers aiming to produce more natural and effective maternal supplements. This study compares the effectiveness of natural [6S]-5-methyltetrahydrofolate (6S-5MTHF) and synthetic folic acid in preserving maternal folate stores in healthy lactating Canadian women.
Study Design and Baseline Characteristics of Folate
Seventy-two healthy pregnant women at 36 weeks gestation who planned to exclusively breastfeed for at least 4 months were recruited, with 64 completing the full 16-week postpartum intervention. Participants were randomized into three groups: 416 μg/d [6S]-5MTHF, 400 μg/d equimolar folic acid (reference group), and placebo. All groups received a folate-free multivitamin and consumed standard folic acid-fortified foods throughout the trial. No significant baseline differences in age, parity, dietary intake or MTHFR genotype were observed across groups; average baseline dietary folate intake was 547 μg DFE per day, and 97% of participants had consumed 1000 μg/d folic acid via prenatal supplements during pregnancy. Notably, Active folate raw material for dietary supplements must meet high purity standards to ensure consistent bioavailability in postpartum formulations.
Comparative Outcomes of Blood Folate Status
After adjusting for baseline folate concentrations, clear differences in long-term folate stores (measured by red blood cell, RBC, folate) emerged at 16 weeks postpartum. The [6S]-5MTHF group had an adjusted mean RBC folate of 2178 nmol/L (95% CI 1854, 2559), which is 10.7% higher than the folic acid group's 1967 nmol/L (95% CI 1628, 2377, P<0.05) and 56.7% higher than the placebo group's 1390 nmol/L (95% CI 1198, 1613, P<0.002). For plasma folate (a marker of recent intake), both supplemented groups had significantly higher levels than placebo: [6S]-5MTHF averaged 91.1 nmol/L, folic acid averaged 93.5 nmol/L, and placebo averaged just 43.5 nmol/L, with no significant difference between the two supplemented groups. Active folate for prenatal supplements should ideally mimic the natural circulating form to support both mother and infant during lactation [2]. Analysis of folate forms found only 5-formyltetrahydrofolate (5-formylTHF) differed significantly: the folic acid group had a 54% higher 5-formylTHF concentration than the [6S]-5MTHF group (368 nmol/L vs 239 nmol/L, P<0.03). Plasma homocysteine showed no significant group differences, with an overall average of 8.4 μmol/L.
Clinical Implications of Trial Findings
The 16-week follow-up period aligns with the full lifespan of mature red blood cells, so the observed RBC folate difference reliably reflects the long-term effectiveness of each supplement. The higher 5-formylTHF level in the folic acid group supports the long-held hypothesis that synthetic folic acid is more likely to mask vitamin B12 deficiency than natural [6S]-5MTHF. Furthermore, Bioavailable Folate Ingredient such as [6S]-5MTHF offers a safer profile for postnatal women, reducing the risk of masked B12 deficiency while maintaining robust RBC folate levels. Synthetic L-5-MTHF Ca remains an option, but clinical evidence increasingly favors the natural form for lactation.
Leadingnutra Supply Bulk L-Methylfolate
At Leadingnutra, we are a professional manufacturer of high-purity L-methylfolate and related active folate ingredients. Our mission is to provide the industry with reliable, bioavailable folate raw materials for dietary supplements and prenatal nutrition. Contact us today to request samples or discuss custom formulations: lily@leadingchemical.com.
Written by Market Director
----Jony Tang
[1] Houghton LA. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr. 2006;83(4):842-850. 
[2] National Institutes of Health. Folate Fact Sheet for Health Professionals.
[3] World Health Organization. Optimal serum and red blood cell folate concentrations in women of reproductive age.
